home / stock / iron / iron news


IRON News and Press, Disc Medicine Inc.

Stock Information

Company Name: Disc Medicine Inc.
Stock Symbol: IRON
Market: NASDAQ

Menu

IRON IRON Quote IRON Short IRON News IRON Articles IRON Message Board
Get IRON Alerts

News, Short Squeeze, Breakout and More Instantly...

IRON - Securities Investigation: Levi & Korsinsky Investigates Disc Medicine, Inc. (IRON) on Behalf of Investors

New York, New York--(Newsfile Corp. - March 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning potential violations of the federal securities laws. On February 13, 2026, Disc disclos...

IRON - Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection

2026-03-01 14:30:00 ET Jean M. Franchi, Chief Financial Officer of Disc Medicine (NASDAQ:IRON) , executed open-market sales of 11,156 shares for approximately $720,000 across three transactions on Feb. 17 and Feb. 18, 2026, as disclosed in a recent SEC Form 4 filing . ...

IRON - Disc Medicine undergoes restructuring plan; slashes 20% of workforce

2026-02-27 17:28:08 ET More on Disc Medicine Disc Medicine: Downgrading As CRL Puts APOLLO Study Into Question Disc Medicine, Inc. (IRON) Discusses FDA Complete Response Letter and Path Forward for Bitopertin Regulatory Approval Transcript Disc Medicine After The CRL...

IRON - Disc Medicine GAAP EPS of -$6.01

2026-02-26 10:13:21 ET More on Disc Medicine Disc Medicine: Downgrading As CRL Puts APOLLO Study Into Question Disc Medicine, Inc. (IRON) Discusses FDA Complete Response Letter and Path Forward for Bitopertin Regulatory Approval Transcript Disc Medicine After The CRL...

IRON - Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Pursuing a traditional approval path for bitopertin in erythropoietic protoporphyria (EPP); Phase 3 APOLLO study is expected to complete enrollment in March 2026 with topline data expected in Q4 2026 Initial data from Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis (MF)...

IRON - Expected US Company Earnings on Thursday, February 26th, 2026

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

IRON - IRON - Historical Price Movements Surrounding Earnings

2026-02-25 17:38:49 ET Disc Medicine, Inc. (IRON) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.23%. The average open to low on the day of earnings was -4.76%. The average open to cl...

IRON - IRON - Historical Earnings Price Analysis

2026-02-25 17:33:50 ET Disc Medicine, Inc. (IRON) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in IRON stock price following earnings has averaged ±1.70% , with a median of 1.20%. ...

IRON - Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction

2026-02-25 15:39:41 ET On February 17, 2026, Hedge fund BVF disclosed a new position in Disc Medicine (NASDAQ:IRON) , acquiring 650,000 shares. According to a recent SEC filing dated February 17, 2026, BVF reported a new position in Disc Medicine, Inc. during the fourth quar...

IRON - Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst

2026-02-25 15:11:16 ET On February 17, 2026, Great Point Partners disclosed a new position in Disc Medicine (NASDAQ:IRON) , acquiring 250,000 shares worth an estimated $19.85 million. According to an SEC filing dated February 17, 2026, Great Point Partners reported a new pos...

Next 10